# Spleen Radiotherapy Decreases Severe CIT in Advanced NSCLC (SPLEENIR)

> **NCT02650700** · NA · COMPLETED · sponsor: **Xinqiao Hospital of Chongqing** · enrollment: 100 (actual)

## Conditions studied

- Chemotherapy in Non-Small Cell Lung Cancer

## Interventions

- **RADIATION:** spleen radiotherapy

## Key facts

- **NCT ID:** NCT02650700
- **Lead sponsor:** Xinqiao Hospital of Chongqing
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08
- **Primary completion:** 2020-04
- **Final completion:** 2020-04
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2022-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02650700

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02650700, "Spleen Radiotherapy Decreases Severe CIT in Advanced NSCLC (SPLEENIR)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02650700. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*